1. Home
  2. ETNB vs SHLS Comparison

ETNB vs SHLS Comparison

Compare ETNB & SHLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • SHLS
  • Stock Information
  • Founded
  • ETNB 2018
  • SHLS 1996
  • Country
  • ETNB United States
  • SHLS United States
  • Employees
  • ETNB N/A
  • SHLS N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • SHLS Semiconductors
  • Sector
  • ETNB Health Care
  • SHLS Technology
  • Exchange
  • ETNB Nasdaq
  • SHLS Nasdaq
  • Market Cap
  • ETNB 864.2M
  • SHLS 778.5M
  • IPO Year
  • ETNB 2019
  • SHLS 2021
  • Fundamental
  • Price
  • ETNB $6.31
  • SHLS $4.63
  • Analyst Decision
  • ETNB Buy
  • SHLS Buy
  • Analyst Count
  • ETNB 7
  • SHLS 21
  • Target Price
  • ETNB $30.33
  • SHLS $10.50
  • AVG Volume (30 Days)
  • ETNB 1.3M
  • SHLS 6.4M
  • Earning Date
  • ETNB 02-27-2025
  • SHLS 02-26-2025
  • Dividend Yield
  • ETNB N/A
  • SHLS N/A
  • EPS Growth
  • ETNB N/A
  • SHLS N/A
  • EPS
  • ETNB N/A
  • SHLS 0.19
  • Revenue
  • ETNB N/A
  • SHLS $422,657,000.00
  • Revenue This Year
  • ETNB N/A
  • SHLS N/A
  • Revenue Next Year
  • ETNB N/A
  • SHLS $11.57
  • P/E Ratio
  • ETNB N/A
  • SHLS $23.85
  • Revenue Growth
  • ETNB N/A
  • SHLS N/A
  • 52 Week Low
  • ETNB $5.99
  • SHLS $4.07
  • 52 Week High
  • ETNB $16.63
  • SHLS $17.50
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 31.27
  • SHLS 38.98
  • Support Level
  • ETNB $5.99
  • SHLS $4.37
  • Resistance Level
  • ETNB $6.65
  • SHLS $6.11
  • Average True Range (ATR)
  • ETNB 0.40
  • SHLS 0.37
  • MACD
  • ETNB -0.14
  • SHLS -0.15
  • Stochastic Oscillator
  • ETNB 15.70
  • SHLS 12.81

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About SHLS Shoals Technologies Group Inc.

Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.

Share on Social Networks: